NBTX-001 | Preclinical | Phase I | Phase II | Phase III | Market |
---|---|---|---|---|---|
Psychiatric | |||||
Post-Traumatic Stress Disorder (PTSD) | |||||
Irritable Bowel Syndrome (IBS) | |||||
Neurodegenerative | |||||
Autism Spectrum Disorders (ASD) | |||||
Alzheimer’s Disease | |||||
Parkinson’s Disease |
NBTX-001 | Preclinical | Phase I | Phase II | Phase III | Market |
---|---|---|---|---|---|
Psychiatric | |||||
Post-Traumatic Stress Disorder (PTSD) | |||||
Irritable Bowel Syndrome (IBS) | |||||
Neurodegenerative | |||||
Autism Spectrum Disorders (ASD) | |||||
Alzheimer’s Disease | |||||
Parkinson’s Disease |